My watch list  

GeneQuine develops gene therapy-based drugs for the treatment of osteoarthritis. The goal is the development of a gene therapy drug for osteoarthritis in humans. However, GeneQuine focuses initially on gaining market authorization for its drug candidates for horses and dogs, because obtaining regulatory approval for veterinary drugs is significantly less costly and markedly faster compared with human medicines.


High-Tech Gründerfonds

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE